SEC Form 4 · accession 0001179110-16-023902
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ji Li
Officer — EVP and Gl. Head of Bus. Dev.
Period of report
May 3, 2016
Accepted (ET)
May 5, 2016 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 3, 2016 | A | 475,000 | $0.00 | A | 475,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1 | $2.05 | May 3, 2016 | A | 2,376,000 | A | — | May 2, 2026 | Ordinary Shares | 2,376,000 | 2,376,000 | D |
Explanation of responses
- F1These securities vest over a four-year period as follows: 25% on the first anniversary of May 3, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter.